Frontier Ip Regulatory News (FIPP)

19 November 2015

AIM: FIPP

Frontier IP Group plc

("Frontier IP", the "Group" or "the Company")

Frontier IP Group Plc is focused on the commercialisation of intellectual property

Financial Highlights

· Total revenue increased by 102% to £1,591,000 (2014: £786,000) - reflecting an unrealised profit on the revaluation of investments of £1,421,000 (2014: £608,000)

· Fair value of portfolio companies increased by 118% to £2,812,000 (2014: £1,291,000)

· Profit before tax of £647,000 (2014: £27,000)

· Basic earnings per share of 2.76p (2014: 0.13p)

· Cash balances at 30 June 2015 of £636,000 (2014: £587,000)

· Net assets per share as at 30 June 2015 of 20.9p (2014: 18.1p)

Operational Highlights

· Placing raised £854,000 (gross)

· Two new portfolio companies added, both from the University of Cambridge

· Portfolio companies Nandi Proteins Ltd and Alusid Ltd secured funding

· Post year-end, portfolio company Pulsiv Solar Ltd secured funding

Neil Crabb, Chief Executive Officer of Frontier IP, said,

"The Group is making good progress in line with its strategy. I am particularly pleased to report the growth in value of our portfolio, as evidenced by the recent fundraisings. We continue to see strong commercial progress in our Core Portfolio building the potential for further uplift in value."

Enquiries

Notes to Editors:

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses. Frontier IP currently has seventeen companies in its portfolio, which exploit IP from a range of institutions. www.frontierip.co.uk 

Chairman's Statement

Performance

I am pleased to report that Frontier IP has made good progress during the year with a significant increase in the value of its portfolio and in extending its access to the highest quality IP.

Frontier IP's core strategy is to generate value by providing best practice IP commercialisation services to institutions and start-ups, to develop a portfolio of companies capable of commercial success and by providing access to capital for these portfolio companies. The Group has made progress in each of these areas over the year.

During the period we extended our sources of deal flow with the addition of two new start-up companies to our portfolio, both based on the work of academics at the Department of Chemical Engineering and Biotechnology at the University of Cambridge.

We have seen excellent progress in our Core Portfolio and we are pleased to report a 118% increase in the value of our portfolio overall.

We provided access to capital for three of our Core Portfolio companies. Nandi Proteins Limited and Alusid Limited both completed successful fundraisings during the period as did, after the year end, Pulsiv Solar Limited. All three fundraisings were achieved at significantly higher valuations, with the latter two driving increased total revenue for the year. Alusid Limited has since commissioned a pilot plant facility to commence manufacture of construction products from waste materials. Nandi continues to make good commercial progress receiving a high level of support from the Frontier IP team and anticipates a further fundraising at a price which would represent a substantial uplift to the last round.

Portfolio

In line with our move towards earning more significant equity holdings in spin-out companies, we received a 40% stake in each of our two most recent portfolio additions, Cambridge Sensor Innovation Limited (formerly Cambridge Sensor Technologies Limited) and Cambridge Simulation Solutions Limited. Both companies were formed to exploit technologies developed by academics at the Department of Chemical Engineering and Biotechnology at the University of Cambridge.

Our portfolio now comprises 17 companies and we look forward to increasing the number and size of our portfolio stakes as we continue to engage with a wide range of potential sources of commercialisable IP.

Results

For the year to 30 June 2015, total revenue increased by 102% to £1,591,000 (2014: £786,000) as a result of booking an unrealised profit of £1,421,000 (2014: £608,000) on the revaluation of investments, principally due to the movement in fair value of two portfolio companies - Alusid Limited and Pulsiv Solar Limited - following successful fundraisings, with Pulsiv Solar's fundraising completing post year end. Revenue from services, principally board retainers, fund management fees and license income, decreased by 4% to £170,000 (2014: £178,000).

The fair value of our portfolio increased by 118% to £2,812,000 (2014: £1,291,000).

Profit before tax increased to £647,000 (2014: £27,000) reflecting the increased revenue offset by the cost of additional resources. The profit per share was 2.76p (2014: 0.13p).

Outlook

Looking ahead, we are working on a number of new opportunities and intend to continue to grow our portfolio by taking more significant stakes and extending our sources of deal flow. In line with our strategy of broadening the range of capital available to our portfolio companies, we expect to see further portfolio fundraisings during the current financial year. We look forward to seeing further progress in these areas over the new financial year.

Andrew Richmond

Chairman

Our Performance

Chief Executive Officer's Statement

The Group is making good progress in line with its strategy. I am particularly pleased to report the growth in value of our portfolio, as evidenced by the recent fundraisings. We continue to see strong commercial progress in our Core Portfolio building the potential for further uplift in value.

Key Performance Indicators

The key performance indicators for the Group are:

The Chairman's Statement and Operational Review contains information on progress in the business during the year.

The Group's services revenue for the year to 30 June 2015 decreased to £170,000 (2014: £178,000) and, with administrative expenses of £945,000 (2014: £769,000), the Group continues to consume significant cash from operating activities. However, the Directors continue to pursue opportunities that will assist in closing the gap.

Operational Review

Corporate

Frontier IP completed a placing in April 2015 to support the development and growth of its relationships, advisory roles and portfolio companies. The placing comprised 4,066,667 new ordinary shares of 10p at a price of 21p per share, raising £854,000 before expenses.  

Portfolio

The Group added two new spin-out companies to its portfolio during the year. These were Cambridge Simulation Solutions Limited and Cambridge Sensor Innovation Limited (formerly Cambridge Sensor Technologies Limited).

The Group received a 40% equity stake in Cambridge Simulation Solutions Limited, a spin-out from the University of Cambridge. Cambridge Simulation was established to exploit the technology developed by Dr. Vassilios Vassiliadis, a Senior Lecturer at the Department of Chemical Engineering and Biotechnology. Dr. Vassiliadis has developed a method to simulate and control complex chemical processes, which potentially has a wide range of commercial applications in industry, including the food and pharmaceutical sectors.

The Group more recently received a 40% equity stake in Cambridge Sensor Innovation Limited, established to exploit a number of technologies developed by Dr. Mark Williamson, a lecturer and researcher at the Department of Chemical Engineering and Biotechnology at the University of Cambridge. Dr. Williamson develops temperature and humidity sensors and control strategies for industrial processes in which the composition of the processing atmosphere is important.

During the year two of our portfolio companies Nandi Proteins Limited and Alusid Limited completed successful fundraisings, as did Pulsiv Solar Limited after the year end. Alusid Limited has since commissioned a pilot plant facility to commence manufacture of construction products from waste materials. Nandi continues to make good commercial progress receiving a high level of support from the Frontier IP team and anticipates a further fundraising at a price which would represent a substantial uplift to the last round.

Sources of IP

In line with reviewing and extending our portfolio pipeline for sources of high-quality IP we have this year added to our portfolio with two companies based on IP developed within the Department of Chemical Engineering and Biotechnology at the University of Cambridge.

Access to Funding

We continue to extend and make use of our network in managing funding rounds for our portfolio companies, with a particular focus on our Core Portfolio. The recent investments in Nandi Proteins, Pulsiv Solar and Alusid were a successful demonstration of this approach. Frontier IP is building an extensive network of funders ranging from institutions, industry investors through to private individuals.

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the year ended 30 June 2015

All of the Group's activities are classed as continuing.

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

At 30 June 2015

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the year ended 30 June 2015

CONSOLIDATED STATEMENT OF CASH FLOWS

For the year ended 30 June 2015

Cash used in operations

NOTES

1. General information

This preliminary announcement was approved for issue by a duly appointed and authorised committee of the Board of Directors on 18 November 2015.

2. Basis of preparation

The financial information set out in this announcement does not constitute statutory financial statements for the year ended 30 June 2015 or 30 June 2014. The report of the auditor on the statutory financial statements for the year ended 30 June 2015 and 30 June 2014 was not qualified, but drew attention by way of emphasis to the uncertainty regarding the Group's ability to generate sufficient working capital to support the ongoing requirements of the Group and the preparation of the financial statements on a going concern basis.

The report of the auditor on the statutory financial statements for each of the years ended 30 June 2015 and 30 June 2014 did not contain statements under section 498(2) or (3) of the Companies Act 2006. The statutory financial statements for the year ended 30 June 2014 have been delivered to the Registrar of Companies. The financial statements for the year ended 30 June 2015 will be delivered to the Registrar of Companies following the Company's Annual General Meeting.

Going Concern

The Group's strategy is to develop a growing portfolio of spin-out companies that will provide cash inflows through realisation of investments and in the meantime will make use of the Group's services in return for cash fees. However, based on forecast income and expenditure for the next 12 months, the Group's cash income will be insufficient to cover the Group's expenditure. Consequently, the Group will require to raise additional capital in order to continue in operational existence for at least the next 12 months. The Directors anticipate undertaking an equity placing by early 2016 and also intend to seek authority to allot securities at the forthcoming Annual General Meeting in December 2015. The Directors have concluded that the necessity to raise additional capital represents a material uncertainty that casts significant doubt upon the Group's ability to continue as a going concern and that should it be unable to raise further funds, the Group may be unable to realise its assets and discharge its liabilities in the normal course of business. Nevertheless, considering the success of previous fundraisings and the current performance of the business, the Directors have a reasonable expectation of raising sufficient additional capital to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the Group's financial statements.

While the financial information included in this preliminary announcement has been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards (IFRS) as adopted by the European Union, this announcement does not itself contain sufficient information to comply with IFRS.

3. Segmental information

The Group operates in one market sector, the commercialisation of university Intellectual Property, and wholly within the UK. Therefore, revenue, profit on ordinary activities before tax and net assets do not need to be analysed by segment.

4. Taxation

There is no charge to taxation for the year ended 30 June 2015 (2014: Nil) due to the Group making a taxable loss.

The Group's deferred tax assets, other than those relating to short term timing differences, are not recognised in accordance with Group policy.

5. Earnings per share

(a) Basic

Basic earnings per share is calculated by dividing the profit attributable to the shareholders of Frontier IP Group Plc by the weighted average number of shares in issue during the year.

(b) Diluted

Diluted earnings per share is calculated by adjusting the weighted number of ordinary shares outstanding to assume conversion of all dilutive potential ordinary shares. The Company has only one category of dilutive potential ordinary shares: share options. A calculation is done to determine the number of shares that could have been acquired at fair value (determined as the average annual market value share price of the Company's shares) based on the monetary value of the subscription rights attached to outstanding share options. The number of shares calculated as above is compared with the number of shares that would have been issued assuming the exercise of the share options.

6. Availability of statutory financial statements

Copies of the full statutory financial statements will be available from the Company's offices at 93 George Street, Edinburgh EH2 3ES no later than 27 November 2015 and are available on its website at www.frontierip.co.uk